Privacy & Cookies Policy
This website uses cookies to improve your experience. We'll assume
you're ok with this, but you can opt-out if you wish.Cookie settings
Perspectives of People Living with HIV-1 on Implementation of Long-Acting Cabotegravir Plus Rilpivirine in US Healthcare Settings: Results from the CUSTOMIZE Hybrid III Implementation-Effectiveness Study. Journal of the International AIDS Society, 25: 1-12.
This website uses cookies to improve your experience. We’ll assume you’re ok with this, but you can opt-out if you wish. [cookie_settings] [cookie_button]